市場調査レポート
商品コード
1298711
経皮パッチ市場:世界の産業動向、シェア、市場規模、成長機会、2023-2028年予測Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
経皮パッチ市場:世界の産業動向、シェア、市場規模、成長機会、2023-2028年予測 |
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
|
経皮パッチの世界市場規模は2022年に76億米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に4.4%の成長率(CAGR)を示し、2028年までに100億米ドルに達すると予測しています。
経皮パッチは、非侵襲的で使いやすいドラッグデリバリー方法で、一定の治療量を所定の時間にわたって血流に投与します。経皮パッチは、バッキング、薬物、メンブレン、接着剤、ライナー、化学増強剤や浸透剤、物理的補助剤、イオントフォレーシスのような微弱電流で構成されています。これらは、皮膚の特性やパッチのデザインに応じて、一定の拡散速度を提供します。最近では、化粧品、外用剤、経皮投与システムとして世界中で広く使用されています。
経皮パッチは、心臓やホルモンの障害、片頭痛、パーキンソン病、アルツハイマー病、脳卒中、ヒト免疫不全ウイルス(HIV)、骨粗鬆症、レストレスレッグ症候群などの治療に有効です。したがって、これらの病気に苦しむ人口の割合が大幅に増加していることは、市場の成長を促す重要な要因の一つとなっています。さらに、これらのパッチは、医薬品を摂取するための伝統的な経口経路を避け、静脈内または非経口療法による不便さを軽減し、胃腸毒性、吐き気、嘔吐を防ぐのに役立つ。さらに、経皮パッチは投与が容易なため、慢性疼痛の長期治療や禁煙治療において患者のコンプライアンスを向上させるために支持を集めています。これとは別に、手頃なコストでより良い治療法を求める需要の高まりと、さまざまな薬物クラスの臨床試験件数の大幅な増加が、市場にプラスの影響を与えています。さらに、感圧接着剤と浸透促進剤のイントロダクションは、製品の拡散と薬物保持能力の向上につながり、市場プレーヤーに有利な機会を提供し、今後数年間で世界中の経皮パッチのアプリケーションを拡大すると予想されています。
The global transdermal skin patches market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028.
Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.
Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, distribution channel and application.
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Matrix
Others
Hospital Pharmacies
Retail Pharmacies
Online Stores
Pain Relief
Smoking Reduction and Cessation Aid
Overactive Bladder
Hormonal Therapy
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group?, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
1. What was the size of the global transdermal skin patches market in 2022?
2. What is the expected growth rate of the global transdermal skin patches market during 2023-2028?
3. What are the key factors driving the global transdermal skin patches market?
4. What has been the impact of COVID-19 on the global transdermal skin patches market?
5. What is the breakup of the global transdermal skin patches market based on the type?
6. What is the breakup of the global transdermal skin patches market based on the application?
7. What are the key regions in the global transdermal skin patches market?
8. Who are the key players/companies in the global transdermal skin patches market?